Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Anand

Showing results (311-320 of 345) with videos related to

Pageof 35
Sort By:
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
Journal of Biomedical Materials Research. Part A|February 26, 2003
Reevaluation of ethylene oxide hemolysis and irritation potentialV P Anand, C P Cogdill, K A Klausner, et al.
Nature Medicine|February 1, 1995
Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor diseaseP Anand, A Parrett, J Martin, et al.
The Journal of Bone and Joint Surgery. British Volume|March 22, 2012
Nerve injuries sustained during warfare: part I--EpidemiologyR Birch, P Misra, M P M Stewart, et al.
The Journal of Bone and Joint Surgery. British Volume|March 22, 2012
Nerve injuries sustained during warfare: part II: OutcomesR Birch, P Misra, M P M Stewart, et al.
Journal of Medicinal Chemistry|February 20, 2013
Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligandsHenry I Mosberg, Larisa Yeomans, Aubrie A Harland, et al.
Peptides|January 1, 1986
A VIP/PHI-containing pathway links urinary bladder and sacral spinal cordS J Gibson, J M Polak, P Anand, et al.
Journal of Medicinal Chemistry|January 28, 2020
Aromatic-Amine Pendants Produce Highly Potent and Efficacious Mixed Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Peptidomimetics with Enhanced Metabolic StabilitySean Henry, Jessica P Anand, Jack J Twarozynski, et al.
Journal of Medicinal Chemistry|May 6, 2016
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) LigandsAubrie A Harland, Aaron M Bender, Nicholas W Griggs, et al.
Pageof 35

Showing results (311-320 of 345) with videos related to

Sort By:
Pageof 35
BJU International|March 31, 2004
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentC M Brady, A N Apostolidis, M Harper, et al.
BJU International|February 7, 2004
Endothelial nitric oxide synthase expression in neurogenic urinary bladders treated with intravesical resiniferatoxinA N Apostolidis, Y Yiangou, C M Brady, et al.
Journal of Biomedical Materials Research. Part A|February 26, 2003
Reevaluation of ethylene oxide hemolysis and irritation potentialV P Anand, C P Cogdill, K A Klausner, et al.
Nature Medicine|February 1, 1995
Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor diseaseP Anand, A Parrett, J Martin, et al.
The Journal of Bone and Joint Surgery. British Volume|March 22, 2012
Nerve injuries sustained during warfare: part I--EpidemiologyR Birch, P Misra, M P M Stewart, et al.
The Journal of Bone and Joint Surgery. British Volume|March 22, 2012
Nerve injuries sustained during warfare: part II: OutcomesR Birch, P Misra, M P M Stewart, et al.
Journal of Medicinal Chemistry|February 20, 2013
Opioid peptidomimetics: leads for the design of bioavailable mixed efficacy μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligandsHenry I Mosberg, Larisa Yeomans, Aubrie A Harland, et al.
Peptides|January 1, 1986
A VIP/PHI-containing pathway links urinary bladder and sacral spinal cordS J Gibson, J M Polak, P Anand, et al.
Journal of Medicinal Chemistry|January 28, 2020
Aromatic-Amine Pendants Produce Highly Potent and Efficacious Mixed Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Peptidomimetics with Enhanced Metabolic StabilitySean Henry, Jessica P Anand, Jack J Twarozynski, et al.
Journal of Medicinal Chemistry|May 6, 2016
Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) LigandsAubrie A Harland, Aaron M Bender, Nicholas W Griggs, et al.
Pageof 35